Results

Total Results: 674 records

Showing results for "central nervous".

  1. hcup-us.ahrq.gov/reports/statbriefs/sb125.pdf
    February 01, 2012 - quartile  50.8   1,343.7a      All other quartiles  51.4   1078.9 Patient residence          Large central …     $2,200  $630  Cancer of head and neck  33,400  7.5  $19,900    $2,600  $666  Cancer of brain and nervous … location is one of six categories as defined by the National Center for Health Statistics: – Large Central … Metropolitan: Central counties of metropolitan areas with a population of 1 million or greater –
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
    December 11, 2018 - relationships with family; it is the leading cause of disability and is often refractory to treatment.2,3 Nervous … distinct disease entity.1 This multifaceted disease is influenced by multiple factors (e.g., genetic, centralnervous system, psychological, and environmental factors), with complex interactions, making assessment … age, sex, presence of comorbidities (e.g., emotional or mood disorders) or degree of nociplasticity/central … report. 11 Literature Databases: Ovid® MEDLINE®, Cochrane Central
  3. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_A.PDF
    January 01, 2004 - SYSTEM 358 0.04 50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 375 0.05 51: VIRAL … SYSTEM NEOPLASMS W/O CC 277 0.03 101: NERVOUS SYSTEM NEOPLASMS W CC 772 0.10 102: NERVOUS SYSTEM NEOPLASMS … SYSTEM W/O CC 737 0.09 341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 837 0.10 342: OTHER DISORDERS OF … NERVOUS SYSTEM W MCC 208 0.03 370: ORBITAL PROCEDURES W/O CC 73 0.01 371: ORBITAL PROCEDURES W CC … Retardation 11 0.00 NEU16: Multiple Sclerosis 499 0.06 NEU17: Myasthenia Gravis 135 0.02 NEU18: Neoplasm: Central
  4. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_B.PDF
    January 01, 2003 - 998 0.13 42: DEGENERATIVE NERVOUS SYSTEM DISORDERS EXC MULT SCLEROSIS 1863 0.23 43: MULTIPLE SCLEROSIS … SYSTEM 330 0.04 50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 395 0.05 51: VIRAL … SYSTEM NEOPLASMS W/O CC 274 0.03 101: NERVOUS SYSTEM NEOPLASMS W CC 737 0.09 102: NERVOUS SYSTEM NEOPLASMS … NERVOUS SYSTEM W MCC 160 0.02 370: ORBITAL PROCEDURES W/O CC 51 0.01 371: ORBITAL PROCEDURES W CC … DS_DX_CATEGORY1 14:47 Friday, June 3, 2005 DS_DX_Category1 Frequency Percent of Total NEU18: Neoplasm: Central
  5. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_SEVERITY.PDF
    January 01, 2002 - SYSTEM & RELATED PROCEDURES 5802 0.07 40: SPINAL DISORDERS & INJURIES 1693 0.02 41: NERVOUS SYSTEM … SYSTEM 3053 0.04 50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 3612 0.05 51: … SYSTEM NEOPLASMS W/O CC 2990 0.04 101: NERVOUS SYSTEM NEOPLASMS W CC 7188 0.09 102: NERVOUS SYSTEM … SYSTEM W/O CC 6361 0.08 341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 6854 0.09 342: OTHER DISORDERS … 93 0.00 NEU16: Multiple Sclerosis 4600 0.06 NEU17: Myasthenia Gravis 1185 0.02 NEU18: Neoplasm: Central
  6. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_B.PDF
    January 01, 2002 - 981 0.12 42: DEGENERATIVE NERVOUS SYSTEM DISORDERS EXC MULT SCLEROSIS 1784 0.23 43: MULTIPLE SCLEROSIS … SYSTEM 322 0.04 50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 360 0.05 51: VIRAL … SYSTEM NEOPLASMS W/O CC 318 0.04 101: NERVOUS SYSTEM NEOPLASMS W CC 699 0.09 102: NERVOUS SYSTEM NEOPLASMS … NERVOUS SYSTEM W MCC 178 0.02 370: ORBITAL PROCEDURES W/O CC 61 0.01 371: ORBITAL PROCEDURES W CC … DS_DX_Category1 Frequency Percent of Total NEU17: Myasthenia Gravis 124 0.02 NEU18: Neoplasm: Central
  7. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_A.PDF
    January 01, 2002 - 965 0.12 42: DEGENERATIVE NERVOUS SYSTEM DISORDERS EXC MULT SCLEROSIS 1729 0.22 43: MULTIPLE SCLEROSIS … SYSTEM 316 0.04 50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 374 0.05 51: VIRAL … SYSTEM NEOPLASMS W/O CC 306 0.04 101: NERVOUS SYSTEM NEOPLASMS W CC 702 0.09 102: NERVOUS SYSTEM NEOPLASMS … NERVOUS SYSTEM W MCC 169 0.02 370: ORBITAL PROCEDURES W/O CC 57 0.01 371: ORBITAL PROCEDURES W CC … 10 **.** NEU16: Multiple Sclerosis 484 0.06 NEU17: Myasthenia Gravis 126 0.02 NEU18: Neoplasm: Central
  8. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_B.PDF
    January 01, 2004 - SYSTEM 332 0.04 50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 388 0.05 51: VIRAL … SYSTEM NEOPLASMS W/O CC 295 0.04 101: NERVOUS SYSTEM NEOPLASMS W CC 773 0.10 102: NERVOUS SYSTEM NEOPLASMS … SYSTEM W/O CC 722 0.09 341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 820 0.10 342: OTHER DISORDERS OF … NERVOUS SYSTEM W MCC 210 0.03 370: ORBITAL PROCEDURES W/O CC 71 0.01 371: ORBITAL PROCEDURES W CC … = 10 **.** NEU16: Multiple Sclerosis 525 0.07 NEU17: Myasthenia Gravis 133 0.02 NEU18: Neoplasm: Central
  9. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2003_SummaryStats_SEVERITY.PDF
    January 01, 2003 - SYSTEM & RELATED PROCEDURES 3000 0.10 40: SPINAL DISORDERS & INJURIES 573 0.02 41: NERVOUS SYSTEM … SYSTEM 2278 0.08 50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 2859 0.10 51: … SYSTEM NEOPLASMS W/O CC 505 0.02 101: NERVOUS SYSTEM NEOPLASMS W CC 607 0.02 102: NERVOUS SYSTEM NEOPLASMS … SYSTEM W/O CC 3507 0.12 341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 1944 0.07 342: OTHER DISORDERS … Retardation 67 0.00 NEU16: Multiple Sclerosis 364 0.01 NEU17: Myasthenia Gravis 211 0.01 NEU18: Neoplasm: Central
  10. www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chapter5.html
    December 01, 2017 - classified as 1) cardiovascular (21.0 percent; e.g., ACE inhibitors, antilipemic agents, beta blockers); 2) centralnervous system (19.0 percent; e.g., antidepressants, non-opioid analgesics); or 3) hormones, synthetics
  11. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.pdf
    January 01, 2019 - Disorders of The Musculoskeletal System & Conn Tissue 250,727 8.2 7 1: Diseases & Disorders of The Nervous … 13.84 4.6 34: Cancer of other urinary organs 1,716 16.14 16.96 5.1 35: Cancer of brain and nervous … 13.44 1.4 80: Multiple sclerosis 6,730 13.80 14.28 3.4 81: Other hereditary and degenerative nervous … 29,165 8.27 8.53 3.2 94: Other ear and sense organ disorders 1,672 13.22 13.64 3.2 95: Other nervous … anomalies 713 15.71 16.69 6.3 215: Genitourinary congenital anomalies 1,201 16.24 16.57 2.1 216: Nervous
  12. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2018.pdf
    January 01, 2018 - System & Conn Tissue 247,955 8.1 7 1: Diseases & Disorders of The Nervous … 13.84 4.6 34: Cancer of other urinary organs 1,716 16.14 16.96 5.1 35: Cancer of brain and nervous … 13.44 1.4 80: Multiple sclerosis 6,730 13.80 14.28 3.4 81: Other hereditary and degenerative nervous … 29,165 8.27 8.53 3.2 94: Other ear and sense organ disorders 1,672 13.22 13.64 3.2 95: Other nervous … anomalies 713 15.71 16.69 6.3 215: Genitourinary congenital anomalies 1,201 16.24 16.57 2.1 216: Nervous
  13. hcup-us.ahrq.gov/db/nation/nrd/NRDIntroduction2022.pdf
    December 01, 2024 - DISEASES AND DISORDERS OF THE KIDNEY AND URINARY TRACT 255,000 18.0 6 1: DISEASES AND DISORDERS OF THE NERVOUS … 13.84 4.6 34: Cancer of other urinary organs 1,716 16.14 16.96 5.1 35: Cancer of brain and nervous … 13.44 1.4 80: Multiple sclerosis 6,730 13.80 14.28 3.4 81: Other hereditary and degenerative nervous … 29,165 8.27 8.53 3.2 94: Other ear and sense organ disorders 1,672 13.22 13.64 3.2 95: Other nervous … anomalies 713 15.71 16.69 6.3 215: Genitourinary congenital anomalies 1,201 16.24 16.57 2.1 216: Nervous
  14. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - performance improvements in patients with AD.6-9 Intranasal insulin is delivered directly to the centralnervous system via the olfactory and trigeminal neural pathways, bypassing the blood-brain barrier … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the centralnervous system and treat neurodegenerative disease.
  15. www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
    June 07, 2016 - Syphilis infection of the central nervous system (neurosyphilis) can occur at any stage of disease and … Syphilis infection of the nervous system (neurosyphilis) can occur at any stage.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - nervous system; GM1 = monosialotetrahexosylganglioside; HSCT = hematopoietic stem- cell transplantation … nervous system embryonal tumors, and germ cell tumors. … • For single HSCT versus conventional therapy for central nervous system embryonal tumors, high-risk … NERVOUS SYSTEM TUMORS Sands SA, Oberg JA, Gardner SL, Whiteley J. … HIGH RISK CNS TUMORS Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors;
  17. hcup-us.ahrq.gov/reports/statbriefs/sb242-Pediatric-ED-Visits-2015.pdf
    January 01, 2015 - 23.7 3 21.5 21.5 22.0 24.8 4 (highest) 15.3 15.2 18.4 24.9 Patient residence, % Large central … Other common reasons included nervous system disorders (4.8 million visits), digestive disorders (3.4 … 0 2,000,000 4,000,000 6,000,000 8,000,000 10,000,000 Respiratory disorders Injury and poisoning Nervous … • Large Central Metropolitan: Counties in a metropolitan area with 1 million or more residents … Metropolitan: Counties in a metropolitan area with 1 million or more residents that do not qualify as large central
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
    August 01, 2023 - Congenital malformations of the central nervous system. In: Gleason CA, Juul SE , eds. … Congenital anomalies of the nervous system: neural tube defects.
  19. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - This drug combination acts on the central nervous system as an appetite suppressant. … Phentermine is a central norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite … This drug combination acts on the central nervous system as an appetite suppressant. 1 Phentermine … is a central norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite suppressant
  20. hcup-us.ahrq.gov/reports/natstats/his95/table2c.htm
    February 11, 2011 - Acronyms used in Table 2: CNS--central nervous system; GI--gastrointestinal; LOS--length of stay in